ABCAM LTD.

Company Overview

Abcam Ltd. is a life-science reagent company that develops and supplies antibodies, proteins, biochemical assay kits, cell-based assay kits, and related research tools used in cell biology, drug discovery, and in vitro testing. Within in vitro toxicology workflows, its portfolio includes cytotoxicity and cell-viability assay kits, oxidative stress and reactive oxygen species detection assays, and supporting reagents used to evaluate compound-induced cellular damage and stress responses.

Danaher Corp. acquired Abcam Ltd. in an all-cash transaction valued at $5.7 billion. It serves pharmaceutical and biotechnology organizations, contract research organizations, and academic laboratories worldwide. Its products support applications ranging from early compound screening to mechanistic cellular investigations. Its assays are compatible with commonly used laboratory platforms, including microplate readers, fluorescence microscopy systems, and flow cytometry instruments, enabling seamless integration into established in vitro testing workflows.

Company's Business Segments

• Products : Abcam primarily generates its revenue from various bioproducts under several antigens such as Primary antibodies, Secondary antibodies, Biochemicals, Isotype controls, Flow cytometry multi-color selector, Kits, Loading controls, Others.